{"slug":"tempus-ai","name":"Tempus AI","name_en":"Tempus AI","ticker":"TEM","updated_at":"2026-07-12T04:00:27.732593+00:00","canonical":"https://valuechain.wiki/tempus-ai","same_as":["https://finance.yahoo.com/quote/TEM","https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1717115"],"citable":"밸류체인 그래프 기준 Tempus AI의 직접 연결 기업은 2곳(관계 기준 공급 2·매출 0)이고, 사슬을 2차까지 넓히면 3곳에 닿는다. 링크의 근거 출처는 3건이며 그중 1차공시가 1건이다 (valuechain.wiki, 2026-07-12 기준).","citable_en":"Per the valuechain.wiki graph, Tempus AI is directly linked to 2 companies (2 supply, 0 revenue relationships) and reaches 3 companies within two hops; the links are backed by 3 dated sources, 1 of them primary filings (as of 2026-07-12).","kicker":"AI 정밀의료 · 유전체 데이터 OS","kicker_en":"AI precision medicine · genomic data OS","lead":"종양 유전자검사를 데이터 수집 깔때기로 삼아 세계 최대급 멀티모달 의료 데이터를 쌓고, 그 데이터를 제약에 되파는 구조의 AI 정밀의료 기업이다. 2025년 매출 $12.7억(+83%) 중 진단(유전자검사)이 75%($955M)로 자본을 대고, 데이터·앱 25%($316M)가 고마진 수익원 — 즉 일루미나 시퀀싱과 엔비디아 컴퓨트를 사서 데이터를 만들어 제약에 파는 노드다. 재평가 축은 아스트라제네카·파토스와의 $200M 종양 파운데이션 모델처럼 데이터→제약 수익화가 자본집약적 진단부문보다 빠르게 커지는지다.","lead_en":"An AI precision-medicine company that uses oncology genetic testing as a data-acquisition funnel to build one of the world's largest multimodal medical datasets and sells that data back to pharma. Of 2025 revenue of $1.27B (+83%), Diagnostics (genetic testing) is 75% ($955M) and funds the model, while Data & Apps at 25% ($316M) is the high-margin leg — it buys Illumina sequencing and NVIDIA compute to create data and sell it to pharma. The re-rating axis is whether data-to-pharma monetization (e.g., the $200M oncology foundation model with AstraZeneca and Pathos) scales faster than the capital-intensive diagnostics leg.","segments":{"fy":2025,"parts":[{"name":"진단(유전체) 75%"},{"name":"데이터·앱 25%"}],"total":"2025 매출 $1.27B (+83%)","concentration":"AZ·파토스 $200M. 진단 $955M."},"segments_en":{"fy":2025,"parts":[{"name":"Diagnostics 75%"},{"name":"Data & Apps 25%"}],"total":"2025 revenue $1.27B (+83%)","concentration":"AstraZeneca/Pathos $200M; diagnostics $955M."},"returns_yearly":{"2025":74.9,"2026":-1.4},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[{"slug":"illumina","name":"Illumina","name_en":"Illumina","tier":1,"returns_yearly":{"2021":2.8,"2022":-46.9,"2023":-31.1,"2024":-1.3,"2025":-1.8,"2026":45}},{"slug":"nvidia","name":"NVIDIA","name_en":"NVIDIA","tier":2,"returns_yearly":{"2021":125.5,"2022":-50.3,"2023":239,"2024":171.2,"2025":38.9,"2026":13.3}},{"slug":"amazon","name":"아마존","name_en":"Amazon","tier":2,"returns_yearly":{"2021":2.4,"2022":-49.6,"2023":80.9,"2024":44.4,"2025":5.2,"2026":6.3}},{"slug":"sandisk","name":"샌디스크","name_en":"SanDisk","tier":3,"returns_yearly":{"2026":707.1}},{"slug":"samsung-electro-mechanics","name":"삼성전기","name_en":"Samsung Electro-Mechanics","tier":3,"returns_yearly":{"2021":-11.8,"2022":-18.5,"2023":-1.4,"2024":-2.5,"2025":110,"2026":467.7}},{"slug":"kioxia","name":"키옥시아","name_en":"Kioxia","tier":3,"returns_yearly":{"2025":1082.1,"2026":260.5}},{"slug":"micron","name":"Micron Technology","name_en":"Micron Technology","tier":3,"returns_yearly":{"2021":24.2,"2022":-45.9,"2023":71.9,"2024":-1,"2025":240.2,"2026":243.3}},{"slug":"seagate","name":"Seagate","name_en":"Seagate Technology","tier":3,"returns_yearly":{"2021":87.5,"2022":-51.4,"2023":69.1,"2024":4.1,"2025":225.3,"2026":231.4}},{"slug":"murata","name":"Murata","name_en":"Murata Manufacturing","tier":3,"returns_yearly":{"2021":-14,"2022":-11.7,"2023":24.7,"2024":-16.5,"2025":29.9,"2026":217.4}},{"slug":"nanya-pcb","name":"난야PCB","name_en":"Nan Ya PCB","tier":3,"returns_yearly":{"2021":110.6,"2022":-46.7,"2023":-0.5,"2024":-38.3,"2025":188.2,"2026":213.4}},{"slug":"lg-innotek","name":"LG이노텍","name_en":"LG Innotek","tier":3,"returns_yearly":{"2021":78.2,"2022":-22,"2023":-28.8,"2024":-22.1,"2025":66.8,"2026":204.6}},{"slug":"arm","name":"Arm Holdings","name_en":"Arm Holdings","tier":3,"returns_yearly":{"2024":64.2,"2025":-11.4,"2026":195.8}},{"slug":"marvell","name":"Marvell","name_en":"Marvell","tier":3,"returns_yearly":{"2021":84.6,"2022":-57.5,"2023":63.7,"2024":83.8,"2025":-22.8,"2026":177.8}},{"slug":"ase","name":"ASE테크놀로지","name_en":"ASE Technology","tier":3,"returns_yearly":{"2021":38.3,"2022":-12.8,"2023":60.9,"2024":10.1,"2025":65.6,"2026":167.6}},{"slug":"nebius","name":"Nebius","name_en":"Nebius Group","tier":3,"returns_yearly":{"2025":202.2,"2026":162.4}},{"slug":"astera-labs","name":"Astera Labs","name_en":"Astera Labs","tier":3,"returns_yearly":{"2025":25.6,"2026":148.2}},{"slug":"ibiden","name":"Ibiden","name_en":"Ibiden","tier":3,"returns_yearly":{"2021":30.4,"2022":-19.6,"2023":51.6,"2024":-38.6,"2025":261,"2026":147.1}},{"slug":"sk-hynix","name":"SK하이닉스","name_en":"SK hynix","tier":3,"returns_yearly":{"2021":-0.4,"2022":-25.6,"2023":53.9,"2024":48.6,"2025":361.1,"2026":140.3}},{"slug":"unimicron","name":"유니마이크론","name_en":"Unimicron","tier":3,"returns_yearly":{"2021":133.5,"2022":-30.2,"2023":35.2,"2024":-19.7,"2025":175.7,"2026":131.6}},{"slug":"mediatek","name":"미디어텍","name_en":"MediaTek","tier":3,"returns_yearly":{"2021":27.8,"2022":-26.6,"2023":52.9,"2024":58.3,"2025":24.9,"2026":124.3}},{"slug":"corning","name":"Corning","name_en":"Corning","tier":3,"returns_yearly":{"2021":5.9,"2022":-11.6,"2023":-1.2,"2024":60.6,"2025":87.8,"2026":118.8}},{"slug":"lumentum","name":"Lumentum","name_en":"Lumentum","tier":3,"returns_yearly":{"2021":11.6,"2022":-50.7,"2023":0.5,"2024":60.1,"2025":339.1,"2026":117.6}},{"slug":"ciena","name":"Ciena","name_en":"Ciena","tier":3,"returns_yearly":{"2021":45.6,"2022":-33.8,"2023":-11.7,"2024":88.4,"2025":175.8,"2026":97}},{"slug":"teradyne","name":"Teradyne","name_en":"Teradyne","tier":3,"returns_yearly":{"2021":36.8,"2022":-46.3,"2023":24.8,"2024":16.5,"2025":54.4,"2026":85.9}},{"slug":"credo","name":"크레도","name_en":"Credo Technology","tier":3,"returns_yearly":{"2023":46.3,"2024":245.2,"2025":114.1,"2026":79.2}},{"slug":"samsung-electronics","name":"삼성전자","name_en":"Samsung Electronics","tier":3,"returns_yearly":{"2021":-9,"2022":-14.2,"2023":20.9,"2024":-26.4,"2025":212.9,"2026":77.9}},{"slug":"onsemi","name":"onsemi","name_en":"onsemi","tier":3,"returns_yearly":{"2021":107.5,"2022":-8.2,"2023":33.9,"2024":-24.5,"2025":-14.1,"2026":77.2}},{"slug":"coherent","name":"Coherent","name_en":"Coherent","tier":3,"returns_yearly":{"2021":-10,"2022":-48.6,"2023":24,"2024":117.6,"2025":94.8,"2026":75.8}},{"slug":"eoptolink","name":"Eoptolink","name_en":"Eoptolink","tier":3,"returns_yearly":{"2021":-10.1,"2022":-27.7,"2023":136.6,"2024":197,"2025":368.8,"2026":74.9}},{"slug":"innolight","name":"InnoLight","name_en":"InnoLight","tier":3,"returns_yearly":{"2021":-30.7,"2022":-18.3,"2023":253.7,"2024":12,"2025":468.1,"2026":68.8}},{"slug":"ge-vernova","name":"GE Vernova","name_en":"GE Vernova","tier":3,"returns_yearly":{"2025":99,"2026":67.3}},{"slug":"caterpillar","name":"Caterpillar","name_en":"Caterpillar","tier":3,"returns_yearly":{"2021":16,"2022":18.6,"2023":25.9,"2024":24.7,"2025":60.3,"2026":67}},{"slug":"keysight","name":"Keysight","name_en":"Keysight Technologies","tier":3,"returns_yearly":{"2021":56.3,"2022":-17.2,"2023":-7,"2024":1,"2025":26.5,"2026":58.5}},{"slug":"delta-electronics","name":"Delta Electronics","name_en":"Delta Electronics","tier":3,"returns_yearly":{"2021":-3.4,"2022":10.4,"2023":-0.3,"2024":59.2,"2025":183.8,"2026":54.9}},{"slug":"monolithic-power","name":"Monolithic Power","name_en":"Monolithic Power","tier":3,"returns_yearly":{"2021":35.5,"2022":-27.8,"2023":79.8,"2024":-5.6,"2025":54.5,"2026":49.8}},{"slug":"analog-devices","name":"Analog Devices","name_en":"Analog Devices","tier":3,"returns_yearly":{"2021":21,"2022":-4.9,"2023":23.4,"2024":8.8,"2025":29.8,"2026":46.7}},{"slug":"wiwynn","name":"Wiwynn","name_en":"Wiwynn","tier":3,"returns_yearly":{"2021":24.7,"2022":-22.3,"2023":206.4,"2024":3.5,"2025":64.4,"2026":45.1}},{"slug":"jabil","name":"자빌","name_en":"Jabil","tier":3,"returns_yearly":{"2021":66.4,"2022":-2.5,"2023":87.4,"2024":13.3,"2025":58.7,"2026":44.9}},{"slug":"tsmc","name":"TSMC","name_en":"TSMC","tier":3,"returns_yearly":{"2021":12.1,"2022":-36.7,"2023":42.3,"2024":92.6,"2025":55.9,"2026":43.6}},{"slug":"arista","name":"Arista Networks","name_en":"Arista Networks","tier":3,"returns_yearly":{"2021":97.9,"2022":-15.6,"2023":94.1,"2024":87.7,"2025":18.5,"2026":42.7}},{"slug":"alchip","name":"알칩","name_en":"Alchip Technologies","tier":3,"returns_yearly":{"2021":14.3,"2022":-8.7,"2023":365.1,"2024":-18.9,"2025":0.8,"2026":34.7}},{"slug":"quanta","name":"Quanta","name_en":"Quanta Computer","tier":3,"returns_yearly":{"2021":22.2,"2022":-12.8,"2023":254.5,"2024":12.7,"2025":8.9,"2026":33.4}},{"slug":"cummins","name":"Cummins","name_en":"Cummins","tier":3,"returns_yearly":{"2021":-1.7,"2022":14.1,"2023":1.7,"2024":48.9,"2025":49.4,"2026":33.3}},{"slug":"globalstar","name":"글로벌스타","name_en":"Globalstar","tier":3,"returns_yearly":{"2021":241.2,"2022":14.7,"2023":45.9,"2024":6.7,"2025":96.6,"2026":31.2}},{"slug":"eaton","name":"Eaton","name_en":"Eaton","tier":3,"returns_yearly":{"2021":46.7,"2022":-7.2,"2023":56.2,"2024":39.5,"2025":-2.8,"2026":28.6}},{"slug":"abb","name":"ABB","name_en":"ABB","tier":3,"returns_yearly":{"2021":23.9,"2022":7.3,"2023":18.9,"2024":39,"2025":36.1,"2026":27.2}},{"slug":"coreweave","name":"CoreWeave","name_en":"CoreWeave","tier":3,"returns_yearly":{"2026":24.1}},{"slug":"pegatron","name":"페가트론","name_en":"Pegatron","tier":3,"returns_yearly":{"2021":-5.9,"2022":0.6,"2023":35.3,"2024":21.2,"2025":-23.8,"2026":24}},{"slug":"cadence","name":"Cadence Design Systems","name_en":"Cadence Design Systems","tier":3,"returns_yearly":{"2021":36.6,"2022":-13.8,"2023":69.6,"2024":10.3,"2025":4,"2026":22.9}},{"slug":"celestica","name":"Celestica","name_en":"Celestica","tier":3,"returns_yearly":{"2021":37.9,"2022":1.3,"2023":159.8,"2024":215.2,"2025":220.3,"2026":21.7}},{"slug":"luxshare","name":"Luxshare","name_en":"Luxshare Precision","tier":3,"returns_yearly":{"2021":-11.9,"2022":-30.2,"2023":-21.2,"2024":58.8,"2025":29.3,"2026":20.6}},{"slug":"digital-realty","name":"Digital Realty","name_en":"Digital Realty","tier":3,"returns_yearly":{"2021":30.7,"2022":-41,"2023":39.9,"2024":35.9,"2025":-10.1,"2026":18.2}},{"slug":"amphenol","name":"Amphenol","name_en":"Amphenol","tier":3,"returns_yearly":{"2021":34.9,"2022":-12,"2023":31.5,"2024":41.3,"2025":96.1,"2026":18.1}},{"slug":"advantest","name":"Advantest","name_en":"Advantest","tier":3,"returns_yearly":{"2021":17,"2022":-2.3,"2023":155.7,"2024":49.5,"2025":196,"2026":17.1}},{"slug":"wistron","name":"위스트론","name_en":"Wistron","tier":3,"returns_yearly":{"2021":7.9,"2022":9.7,"2023":272.7,"2024":-1.6,"2025":22.7,"2026":14.8}},{"slug":"schneider-electric","name":"Schneider Electric","name_en":"Schneider Electric","tier":3,"returns_yearly":{"2021":25.9,"2022":1.6,"2023":25.8,"2024":36.1,"2025":0.5,"2026":13}},{"slug":"foxconn","name":"Foxconn","name_en":"Foxconn (Hon Hai)","tier":3,"returns_yearly":{"2021":-5.1,"2022":2.8,"2023":7.8,"2024":80.1,"2025":26.9,"2026":10.9}},{"slug":"exelon","name":"엑셀론","name_en":"Exelon","tier":3,"returns_yearly":{"2021":41.5,"2022":8.3,"2023":-14,"2024":9.2,"2025":20,"2026":9.3}},{"slug":"kyec","name":"KYEC","name_en":"King Yuan Electronics (KYEC)","tier":3,"returns_yearly":{"2021":26.7,"2022":-7.7,"2023":132.4,"2024":38.6,"2025":171,"2026":4.2}},{"slug":"procter-gamble","name":"Procter & Gamble","name_en":"Procter & Gamble","tier":3,"returns_yearly":{"2021":20.5,"2022":-5,"2023":-0.9,"2024":17.3,"2025":-12.3,"2026":4.1}},{"slug":"fabrinet","name":"Fabrinet","name_en":"Fabrinet","tier":3,"returns_yearly":{"2021":52.7,"2022":8.2,"2023":48.4,"2024":15.5,"2025":107.1,"2026":3.5}},{"slug":"talen-energy","name":"Talen Energy","name_en":"Talen Energy","tier":3,"returns_yearly":{"2024":214.8,"2025":86.1,"2026":2.9}},{"slug":"vistra","name":"Vistra","name_en":"Vistra","tier":3,"returns_yearly":{"2021":19.6,"2022":5.1,"2023":70.7,"2024":261.5,"2025":17.7,"2026":-1.3}},{"slug":"blackrock","name":"BlackRock","name_en":"BlackRock","tier":3,"returns_yearly":{"2021":29.4,"2022":-20.4,"2023":17.9,"2024":29.3,"2025":6.6,"2026":-2.1}},{"slug":"ionq","name":"IonQ","name_en":"IonQ","tier":3,"returns_yearly":{"2022":-79.3,"2023":259.1,"2024":237.1,"2025":7.4,"2026":-4.5}},{"slug":"synopsys","name":"Synopsys","name_en":"Synopsys","tier":3,"returns_yearly":{"2021":42.1,"2022":-13.4,"2023":61.3,"2024":-5.7,"2025":-3.2,"2026":-5.2}},{"slug":"amorepacific","name":"아모레퍼시픽","name_en":"Amorepacific","tier":3,"returns_yearly":{"2021":-30.1,"2022":-5.7,"2023":-18.4,"2024":9.9,"2025":8.2,"2026":-10.5}},{"slug":"te-connectivity","name":"TE Connectivity","name_en":"TE Connectivity","tier":3,"returns_yearly":{"2021":35.1,"2022":-27.7,"2023":24.6,"2024":3.5,"2025":61.1,"2026":-11.3}},{"slug":"recursion","name":"Recursion Pharmaceuticals","name_en":"Recursion Pharmaceuticals","tier":3,"returns_yearly":{"2022":-55,"2023":27.9,"2024":-31.4,"2025":-39.5,"2026":-13}},{"slug":"qubt","name":"Quantum Computing Inc","name_en":"Quantum Computing Inc","tier":3,"returns_yearly":{"2021":-75.8,"2022":-55.7,"2023":-39.5,"2024":1712.7,"2025":-38,"2026":-15.6}},{"slug":"d-wave","name":"D-Wave Quantum","name_en":"D-Wave Quantum","tier":3,"returns_yearly":{"2022":-85.3,"2023":-38.9,"2024":854.5,"2025":211.3,"2026":-23.2}},{"slug":"rigetti","name":"Rigetti Computing","name_en":"Rigetti Computing","tier":3,"returns_yearly":{"2022":-92.9,"2023":35.1,"2024":1449.2,"2025":45.2,"2026":-25.3}},{"slug":"nike","name":"Nike","name_en":"Nike","tier":3,"returns_yearly":{"2021":18.7,"2022":-29,"2023":-6,"2024":-29.1,"2025":-13.8,"2026":-29.3}},{"slug":"byd-electronics","name":"BYD일렉트로닉스","name_en":"BYD Electronics","tier":3,"returns_yearly":{"2021":-56.1,"2022":16,"2023":-0.4,"2024":60.6,"2025":-19.4,"2026":-34.4}},{"slug":"siemens-eda","name":"Siemens EDA","name_en":"Siemens EDA","tier":3,"returns_yearly":null},{"slug":"openai","name":"OpenAI","name_en":"OpenAI","tier":3,"returns_yearly":null},{"slug":"anthropic","name":"Anthropic","name_en":"Anthropic","tier":3,"returns_yearly":null},{"slug":"cerebras","name":"Cerebras","name_en":"Cerebras Systems","tier":3,"returns_yearly":null},{"slug":"arianegroup","name":"아리안그룹","name_en":"ArianeGroup","tier":3,"returns_yearly":null}],"analysis":"텐푸스의 투자 논점은 '진단으로 데이터를 모아 제약에 파는 플라이휠'이다. 진단(매출 75%·$955M)은 그 자체 이익보다 멀티모달 데이터를 쌓는 깔때기이고, 데이터·앱(25%·$316M)이 고마진 수익화 레그다 — AZ·파토스와의 $200M 파운데이션 모델이 이 전환의 증거다. 그래프상 이 노드는 상류로 일루미나(시퀀싱)·엔비디아(컴퓨트)를 사서, 하류로 병원 검사와 제약 데이터 라이선스로 판다. 관건은 매출 +83% 성장이 데이터 레그의 규모화로 이어져 진단의 자본집약성을 넘어서는지이며, 리스크는 컴퓨트·시퀀싱 원가와 데이터 수익화 속도다.","analysis_en":"Tempus's thesis is a flywheel — collect data through diagnostics, sell it to pharma. Diagnostics (75% of revenue, $955M) matters less for its own profit than as the funnel that accumulates multimodal data, while Data & Apps (25%, $316M) is the high-margin monetization leg — the $200M foundation-model deal with AstraZeneca and Pathos is the proof of that shift. In the graph this node buys Illumina (sequencing) and NVIDIA (compute) upstream and sells hospital testing and pharma data licenses downstream. The question is whether +83% revenue growth scales the data leg past the capital intensity of diagnostics; the risks are compute/sequencing cost and the pace of data monetization.","analysis_asof":"2026-07-09"},"edges":[{"direction":"revenue","counterparty":"병원·진단 (종양 유전자검사)","counterparty_slug":null,"confidence":"high","metric":null,"note":"병원·임상에 종양 DNA·RNA·액체생검 검사(매출 75%).","note_en":"Oncology DNA/RNA and liquid-biopsy testing to hospitals (75% of revenue).","sources":[{"stance":"confirms","publisher":"Tempus","publisher_en":"Tempus","kind":"filing","lang":"en","published_at":"2026-02-24","url":"https://www.tempus.com/news/pr/tempus-reports-fourth-quarter-and-full-year-2025-results/","title":"Tempus FY2025 실적($1.27B·+83%)","title_en":"Tempus FY2025 results ($1.27B, +83%)","excerpt":"병원·임상에 종양 DNA·RNA·액체생검 검사(매출 75%).","excerpt_en":"Oncology DNA/RNA and liquid-biopsy testing to hospitals (75% of revenue)."},{"stance":"confirms","publisher":"Seeking Alpha","publisher_en":"Seeking Alpha","kind":"research","lang":"en","published_at":"2026-01-01","url":"https://seekingalpha.com/article/4854303-tempus-ai-a-healthcare-hyper-growth-opportunity-for-the-risk-tolerant","title":"Tempus, 헬스케어 초고속 성장","title_en":"Tempus, a healthcare hyper-growth opportunity","excerpt":"병원·임상에 종양 DNA·RNA·액체생검 검사(매출 75%).","excerpt_en":"Oncology DNA/RNA and liquid-biopsy testing to hospitals (75% of revenue)."}]},{"direction":"revenue","counterparty":"제약 (AZ·파토스 데이터·파운데이션 모델)","counterparty_slug":null,"confidence":"high","metric":null,"note":"아스트라제네카·파토스 등 제약에 데이터 라이선스·파운데이션 모델($200M).","note_en":"Data licensing and foundation-model fees ($200M) to pharma like AstraZeneca and Pathos.","sources":[{"stance":"confirms","publisher":"Tempus","publisher_en":"Tempus","kind":"filing","lang":"en","published_at":"2026-02-24","url":"https://www.tempus.com/news/pr/tempus-reports-fourth-quarter-and-full-year-2025-results/","title":"Tempus FY2025 실적($1.27B·+83%)","title_en":"Tempus FY2025 results ($1.27B, +83%)","excerpt":"아스트라제네카·파토스 등 제약에 데이터 라이선스·파운데이션 모델($200M).","excerpt_en":"Data licensing and foundation-model fees ($200M) to pharma like AstraZeneca and Pathos."},{"stance":"confirms","publisher":"Yahoo Finance","publisher_en":"Yahoo Finance","kind":"news","lang":"en","published_at":"2026-01-01","url":"https://finance.yahoo.com/sectors/healthcare/articles/tempus-ais-diagnostics-data-arms-160300587.html","title":"Tempus, 진단·데이터 성장(AZ 파운데이션 모델)","title_en":"Tempus diagnostics and data arms drive growth (AZ foundation model)","excerpt":"아스트라제네카·파토스 등 제약에 데이터 라이선스·파운데이션 모델($200M).","excerpt_en":"Data licensing and foundation-model fees ($200M) to pharma like AstraZeneca and Pathos."}]},{"direction":"cost","counterparty":"Illumina","counterparty_slug":"illumina","confidence":"mid","metric":null,"note":"유전체 검사의 출발 원가인 시퀀싱을 일루미나 등에 의존 — 진단(매출 75%)이라는 데이터 깔때기를 돌리는 핵심 상류 투입이라, 시퀀싱 단가가 진단 부문 마진을 좌우한다.","note_en":"Depends on Illumina and others for sequencing, the starting cost of genetic testing — the key upstream input that powers the diagnostics data-funnel (75% of revenue), so sequencing unit cost drives the segment's margin.","sources":[{"stance":"confirms","publisher":"Tempus","publisher_en":"Tempus","kind":"filing","lang":"en","published_at":"2026-02-24","url":"https://www.tempus.com/news/pr/tempus-reports-fourth-quarter-and-full-year-2025-results/","title":"Tempus FY2025 실적($1.27B·+83%)","title_en":"Tempus FY2025 results ($1.27B, +83%)","excerpt":"유전체 검사용 시퀀싱을 일루미나 등에서.","excerpt_en":"Sources sequencing for genomic testing from Illumina and others."}]},{"direction":"cost","counterparty":"NVIDIA","counterparty_slug":"nvidia","confidence":"mid","metric":null,"note":"파운데이션 모델 학습의 컴퓨트를 엔비디아에 의존 — 데이터를 제약에 팔 수 있는 '모델'을 만드는 상류 원가로, 데이터 규모가 커질수록 컴퓨트 비용도 함께 커지는 구조.","note_en":"Depends on NVIDIA for the compute to train foundation models — the upstream cost of building the 'model' it sells to pharma, where compute spend scales with the growing dataset.","sources":[{"stance":"confirms","publisher":"Yahoo Finance","publisher_en":"Yahoo Finance","kind":"news","lang":"en","published_at":"2026-01-01","url":"https://finance.yahoo.com/sectors/healthcare/articles/tempus-ais-diagnostics-data-arms-160300587.html","title":"Tempus, 진단·데이터 성장(AZ 파운데이션 모델)","title_en":"Tempus diagnostics and data arms drive growth (AZ foundation model)","excerpt":"멀티모달 파운데이션 모델 학습에 NVIDIA 컴퓨트.","excerpt_en":"NVIDIA compute to train multimodal foundation models."}]},{"direction":"cost","counterparty":"클라우드·실험실 (비공개)","counterparty_slug":null,"confidence":"low","metric":null,"note":"클라우드·검사실 운영.","note_en":"Cloud and lab operations.","sources":[{"stance":"confirms","publisher":"Tempus","publisher_en":"Tempus","kind":"filing","lang":"en","published_at":"2026-02-24","url":"https://www.tempus.com/news/pr/tempus-reports-fourth-quarter-and-full-year-2025-results/","title":"Tempus FY2025 실적($1.27B·+83%)","title_en":"Tempus FY2025 results ($1.27B, +83%)","excerpt":"클라우드·검사실 운영.","excerpt_en":"Cloud and lab operations."}]}]}